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Background: Data about molecular diversity of commonly circulating type A influenza viruses in Ontario swine are
scarce. Yet, this information is essential for surveillance of animal and public health, vaccine updates, and for
understanding virus evolution and its large-scale spread.
Methods: The study population consisted of 21 swine herds with clinical problems due to respiratory disease. Nasal
swabs from individual pigs were collected and tested by virus isolation in MDCK cells and by rtRT-PCR. All eight
segments of 10 H3N2 viruses were sequenced using high-throughput sequencing and molecularly characterized.
Results: Within-herd prevalence ranged between 2 and 100%. Structurally, Ontario H3N2 viruses could be classified
into three different groups. Group 1 was the most similar to the original trH3N2 virus from 2005. Group 2 was the
most similar to the Ontario turkey H3N2 isolates with PB1 and NS genes originating from trH3N2 virus and M, PB2,
PA and NP genes originating from the A(H1N1)pdm09 virus. All Group 3 internal genes were genetically related to
A(H1N1)pdm09. Analysis of antigenic sites of HA1 showed that Group 1 had 8 aa changes within 4 antigenic sites,
A(1), B(3), C(2) and E(2). The Group 2 viruses had 8 aa changes within 3 antigenic sites A(3), B(3) and C(2), while
Group 3 viruses had 4 aa changes within 3 antigenic sites, B(1), D(1) and E(2), when compared to the cluster IV
H3N2 virus [A/swine/Ontario/33853/2005/(H3N2)].
Conclusions: The characterization of the Ontario H3N2 viruses clearly indicates reassortment of gene segments
between the North American swine trH3N2 from cluster IV and the A(H1N1)pdm09 virus.
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Influenza viruses, belonging to the family Orthomyxoviridae,
are enveloped viruses with segmented negative-sense RNA
genome [1]. Influenza A viruses evolve rapidly, creating
new variants which could be the result of either point mu-
tations or reassortment. Eighteen hemagglutinin (HA) and
11 neuraminidase (NA) types have been reported to date,
classifying viruses into subtypes H1 to H18 and N1 to
N11 [2].* Correspondence: hgrgic@uoguelph.ca
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unless otherwise stated.In 2005, the triple-reassortant H3N2 (trH3N2) virus was
reported in Canada and spread widely, affecting swine in-
dustries in all provinces [3]. After initial detection of the
trH3N2 virus in 2005, there were no further scientific pub-
lications about molecular diversity of influenza viruses cir-
culating in Canadian swine until 2009 [4]. This information
has been particularly limited in Ontario. According to a re-
cent statistic from 2012 and 2013, Ontario is the province
with the second largest number of pigs on farms in Canada,
and with the largest number of farms with pigs [5]. This in-
formation is important for surveillance of influenza viruses
and informing animal and public health decisions, vaccine
updates, and for understanding virus evolution and its
large-scale spread. Therefore, the objective of this studytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lated in Ontario swine in 2011 and 2012.
Results
Descriptive analysis
Most of the 21 herds included in this study were finisher
sites only (n = 9), followed by nursery (n = 6), wean-to-
finish (n = 3), farrow-to-finish (n = 1), farrow-to-grow (n = 1),
and farrow-to-wean (n = 1) sites. Sow capacity ranged
between 600 and 650 sows. Nursery inventory at the date
of sampling ranged between 2000 and 2500 animals, and
finisher pig inventory ranged between 950 and 5000 ani-
mals. The average number of samples tested per herd was
56 (7–100), and the average number of pooled real-time
reverse transcription PCR (rtRT-PCR) tests was 10 (5–20)
per herd. The mean number of sampled animals was 53
and 57.3 animals in influenza-virus-negative and influenza-
virus-positive herds, respectively (p = 0.7).
In this study, 13 of 21 herds (61.9%) tested positive for
influenza virus using virus isolation in Madin-Darby ca-
nine kidney (MDCK) cells, while 8 of 12 herds (66.7%)
tested rtRT-PCR-positive on pooled samples. In total, 16
herds (76.2%) tested positive by either virus isolation or
rtRT-PCR. Viruses from eleven out of 16 positive herds
were typed as H3N2, from 3 herds were typed as H1N1,
and in 2 herds, subtyping was not successful. In total 11
H3N2 isolates from 10 different herds were included for
full genome sequencing in 2 separate runs. However, se-
quencing results for 10 isolates from 9 herds were ob-
tained. Full genome sequencing results for one virus
could not be obtained despite repeated inclusion of this
virus in two separate runs.Figure 1 Within-herd prevalence of positive samples for influenza vir
Madin-Darby canine kidney (MDCK) cells, and during testing of 3:1 po
in Ontario swine herds during 2011–2012.Figure 1 depicts the within-herd prevalence of influenza
virus shedding in 21 Ontario swine herds tested by MDCK
and rtRT-PCR. The within-herd prevalence ranged be-
tween 2% and 100%. In herds that had at least one virus
positive isolation, the mean within-herd prevalence was
84% in sow herds (n = 2), 46% in nursery herds (n = 6),
30% in finisher herds (n = 4), and 57% in wean-to-finish
herds (n = 1).
Genetic characterization of 10 Ontario H3N2 influenza
viruses
Structurally, Ontario H3N2 viruses detected in this study
could be classified into three groups. The first group con-
sisted of 4 viruses in which all segments were similar to
those of the trH3N2 virus that emerged in Ontario in
2005 [3]. The second group consisted of 4 viruses with
HA, NA, PB1 and NS genes originating from the trH3N2
virus, and M, PB2, PA and NP genes originating from the
pandemic A(H1N1)pdm09 virus. The third group con-
sisted of 2 viruses with HA and NA genes originating from
the trH3N2 virus, and with all internal genes originating
from the A(H1N1)pdm09 virus. The phylogenetic rela-
tionships of the HA gene of these Ontario H3N2 viruses
are presented, in association with other reference viruses
in Figure 2. Genome constellations identified in Ontario
H3N2 viruses isolated from swine in 2011 and 2012 are
presented in Additional file 1. The GenBank accession
numbers of the sequences reported in this paper are:
[KF840476-KF840478, KJ413857-KJ413933].
More detailed analysis of HA and NA genes revealed that
Group 1 indeed was the most similar to the original Cluster
IV trH3N2 [A/swine/ON/33853/2005 (H3N2] virus fromus during testing of individual samples by virus isolation in
ols of nasal swabs on real-time reverse transcription (rtRT)-PCR
Figure 2 Phylogenetic tree of the HA gene nucleotide sequences of 10 Ontario H3N2 viruses.
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HA and NA genes, respectively (Tables 1 and 2). Interest-
ingly, when compared to published standards, the NA gene
of these Group 1 viruses showed the highest identity (at
98.3% to 98.7%) (Table 2) with the two 2011 Ontario turkey
isolates, while the HA gene of 4 Group 1 viruses showed
much more modest identity with these 2 turkey viruses
(94.6% to 94.7%) (Table 1). Group 1 was a homogenous
group of 4 viruses, with 99.9% to 100% (HA) and 99.7% to
100% (NA) identity of the HA and NA genes, although
these herds were not a part of the same production system.
More detailed analysis of HA and NA genes revealed
that the 4 Group 2 viruses could also be grouped with
Cluster IV viruses. Group 2 was most similar to the 2
Ontario turkey H3N2 variants detected in 2011 [6], with
99.6% to 99.7% and 99.4% to 99.6% identity on HA
(Table 1) and NA (Table 2) genes, respectively. Interest-
ingly, when compared to published standards, the HA
gene of these 4 Group 2 viruses showed a high identity
(at 98.6% to 98.8%) (Table 1) with the 2010 Quebec
swine isolates. However, the NA gene of viruses showed
an identity of only 95.8% to 96.0% with these Quebec
swine viruses (Table 2). Group 2 was also a homogenous
group of viruses with 99.9% to 100% and 99.9% to 100%
identity of the HA and NA genes, respectively, althoughthese herds were not a part of the same production
system.
More detailed analysis of HA and NA genes revealed
that the 2 Group 3 viruses could also be grouped with
Cluster IV viruses. Group 3 viruses were most similar to
the original trH3N2 [A/turkey/ON/31232/2005 and A/
swine/ON/33853/2005(H3N3)] viruses detected in 2005
[3], with 96.8% to 97.1% and 98% to 98.1% identity of HA
and NA genes, respectively. Interestingly, when compared
to published standards, the HA and NA genes of this
group of viruses showed maximum identity of 95.9% and
97.4% of the HA and NA gene, respectively, with any of
the recent Canadian isolates available at the time of this
study (Tables 1 and 2). This was also a homogenous group
of viruses, with 99.5% and 99.9% identity of HA and NA
genes, respectively, but both isolates were from a single
herd.
The relatedness of each internal gene segment from
each of the 10 Ontario H3N2 viruses was compared with
published influenza A virus sequences. More detailed ana-
lysis of internal genes showed that the 4 Group 1 viruses
indeed were the most similar to the original trH3N2 virus
from 2005. The 4 Group 2 viruses were most similar to
the Ontario turkey H3N2 variants with PB1 and NS genes
originating from trH3N2 virus and M, PB2, PA, and NP
Table 1 Identity table of the full length of the HA gene of 10 Ontario H3N2 viruses isolated from swine in 2011–2012
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Table 1 Identity table of the full length of the HA gene of 10 Ontario H3N2 viruses isolated from swine in 2011–2012
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Table 1 Identity table of the full length of the HA gene of 10 Ontario H3N2 viruses isolated from swine in 2011–2012








94.1 94.1 94.1 94.1 93.8 93.9 93.9 93.9 93.6 93.9
TX/4199-2/
98
















92.7 92.7 92.7 92.7 92.1 92.2 92.2 92.2 92.1 92.3
Grgić et al. Virology Journal 2014, 11:194 Page 6 of 14
http://www.virologyj.com/content/11/1/194genes originating from A(H1N1)pdm09 virus. For the 2
Group 3 viruses, all internal genes were genetically related
to A(H1N1)pdm09. Phylogenetic trees for the internal
gene segments are presented in Additional file 2.
HA1 amino acid analysis
In order to determine whether the aa changes occurred in
any of the previously identified antigenic sites A, B, C, D
and E [7], we aligned the aa sequences of the 10 Ontario
H3N2 viruses and compared them with the prototype
cluster IV H3N2 virus [A/swine/Ontario/33853/2005/
(H3N2)]. Antigenic sites are shown in Figure 3. When
compared to the known cluster IV H3N2 virus[A/swine/
Ontario/33853/2005/(H3N2)], the 4 Ontario H3N2 vi-
ruses classified in Group 1 had 8 aa changes within 4 anti-
genic sites, A(1), B(3), C(2) and E(2). The 4 Group 2
viruses had 8 aa changes within 3 antigenic sites, A(3), B(3)
and C(2), and the 2 Group 3 viruses had 4 aa changes
within 4 antigenic sites, B(1), D(1) and E(2).
The Ontario H3N2 viruses from this study exhibited
some unique changes at antigenic site B (Figure 3). Amino
acids at position 155–160 (HNLDYK) related to prototype
cluster IV virus were changed to YNLNYK (Group 1),
YHLGHK (Group 2) and YHLNHK (Group 3). The recep-
tor binding site (RBS) of the Ontario isolates examined in
this study was conserved. The amino acids Y98, G134,
S136, W153, H183, Y195, G225, and S227 were the same
for the Ontario isolates and the prototype IV H3N2 virus
(Figure 3). Identical amino acids of receptor binding
pockets were also observed between isolates detected in
this study and the turkey isolates reported previously and
included in the analysis. The motif, N-X-T/S (X cannot be
a proline) of the N-glycosylation site also has beendetermined (Figure 3). Representative of cluster IV, the
H3N2 [A/swine/Ontario/33853/2005/(H3N2)] virus had 7
potential glycosylation sites at positions 22, 38, 63, 126,
165, 246, and 285 (underlined in Figure 3). Seven potential
glycosylation sites have been predicted for Group 1 at
position 8, 22, 38, 63, 126, 246, and 285. In this group
one virus (A/swine/Ontario/114-13/2012(H3N2) had an
additional potential glycosylation site at residue 165. Six
glycosylation sites have been predicted for Group 2 (22,
38, 63, 165, 246, and 285) and seven (22, 38, 63, 126, 165,
246, and 285) for Group 3 Ontario H3N2 viruses (under-
lined in Figure 3).
Resistance-associated mutations
Two classes of antiviral drugs are currently approved
for prophylaxis and treatment of influenza A viruses in
humans: adamantane derivatives (amantadine and riman-
tadine) and neuraminidase inhibitors (NAIs) (zanamivir
and oseltamivir). To determine resistance-associated mu-
tations to these two classes of drugs, we aligned and ana-
lyzed the aa sequences of the M and NA proteins of all 10
Ontario swH3N2 isolates (Figure 4). The most common
mutation conferring resistance to adamantanes is an aa
change from Ser to Asn at residue 31 (S31N) located in
the transmembrane domain of the M2 protein. Sequence
alignment analysis has shown that 6 of 10 Ontario
swH3N2 isolates (Group 2, 3) do have the S31N mutation
in the M2 protein, suggesting that Ontario swH3N2 iso-
lates can be expected to offer resistance to amantadine
and rimantadine (Figure 4). Besides the S31N mutation,
additional substitutions have been traced. The R77Q sub-
stitution was observed only among 6 Ontario swH3N2
isolates with the S31N mutation. The remaining 4 isolates
Table 2 Identity table of the full length of the NA gene of 10 Ontario H3N2 viruses isolated from swine in 2011–2012
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Table 2 Identity table of the full length of the NA gene of 10 Ontario H3N2 viruses isolated from swine in 2011–2012
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Table 2 Identity table of the full length of the NA gene of 10 Ontario H3N2 viruses isolated from swine in 2011–2012
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(Figure 4).
Resistance-associated mutations within the neuramin-
idase E119V, R292K and N294S, responsible for reduced
susceptibility to oseltamivir, were not detected in any of
the Ontario swH3N2 sequences (data not shown).
Signature residues
Influenza virus segment 2 encodes 3 proteins, PB1, PB1-
F2 encoded by an alternative open reading frame (ORF)
of segment 2, and PB1 N40 N-terminally truncated ver-
sion of the PB1 protein. Phylogenetic analysis of 32 PB1
aa sequences showed that PB1-F2 of all 10 Ontario
H3N2 viruses belongs to lineage D (Additional file 3).
Eight of 10 Ontario H3N2 viruses (Figure 5) had
complete 90 aa PB1-F2 fragments (long bar). The re-
maining 2 viruses (A/sw/Ontario/103-18/2011(H3N2)) and
(A/sw/Ontario/11-105317/2011(H3N2)) from Group 3
expressed a truncated form of PB1-F2 containing 11 aminoFigure 3 Alignment of the 10 Ontario H3 HA1 amino acid sequences
Ontario H3N2 isolates and prototype cluster IV trH3N2 virus [A/swine/ON/3
antigenic sites A, B, C, D and E; respectively. Potential glycosylation sites areacids (short bar), lacking the mitochondrial targeting se-
quence (MTS) located in the C-terminal region. Further
sequence analysis of Ontario H3N2 PB1-F2 proteins re-
vealed the absence of the N66S mutation which was previ-
ously reported in the H1N1, 1918 PB1-F2 and pathogenic
avian H5N1 viruses and found to be associated with a gain
in virulence. In addition to N66S, further amino acids
T51, V56 and E87 might also enhance pathogenicity. As
can be seen from Figure 5 the aa sequences of Ontario
H3N2 PB1-F2 all contain V56, but substitutions T51M
and E87G, previously associated with lower pathogenicity,
have also been determined [8].
Further, we assessed PB2 signature amino acids, which
greatly influences host range. The PB2 key signature aa
at position 627 is an important determinant of virulence
and host specificity [9-11]. This analysis demonstrated
the absence of a PB2 E627K mutation, but revealed 590-
91SR and 271A mutations in all Ontario H3N2 viruses
(data not shown). The H1N1 2009 pandemic viruses alsowithout signal peptide. Amino acids of the HA1 subunit of the 10
3853/2005]. Residues shown in boxes represent previously identified
underlined.
Figure 4 Alignment analysis of M2 sequences of 10 Ontario swH3N2 isolates showing amino acid substitution S31N and V27I within
the transmembrane domain of M2 protein, and R77Q substitution.
Figure 5 Presentation of PB1-F2 variants of mammalian and avian influenza A viruses. Nine PB1 lineages from A to I have been described
and some selected sequences within these lineages are presented. Lines at the top of the Figure represent amino acids of the predicted helical
region (black) and the putative mitochondrial targeting sequence (dashed). Amino acids that are considered to enhance viral pathogenesis are
marked in grey. The first stop codon has been shown by asterisk and following stop codons are indicated by subsequent asterisk.
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tations. Such a distribution of mutations might compen-
sate for PB2 627E and adapt the viruses for efficient
replication in mammals.
Signature residues of the PA protein have also been
assessed and showed the absence of PA 100A that is
present in human influenza A viruses that caused the
pandemic of 1977 A(H1N1), 1968 A(H3N2), and 1957 A
(H2N2). Instead of 100A, Ontario swH3N2 isolates had
PA 100 V. Additional mutations, PA 356R and 409 N as-
sociated with past influenza pandemics, including 2009
(H1N1), 1977 (H1N1), 1968 (H3N2) and 1997 (H5N1),
respectively, have also been detected in Ontario swH3N2
isolates (data not shown).
Close attention has been paid to the NP protein as a
part of the helical genomic ribonucleoprotein complex
with an important role in viral RNA replication and cross-
species transmission. The NP protein with isoleucine at
position NP 100, associated with increased human-to-
human transmissibility, found in both 2009 and 1918
H1N1 pandemic viruses, has not been detected in Ontario
swH3N2 isolates. Instead of an isoleucine residue, glycine
was detected (data not shown).
Discussion
In this report we describe the genetic and predicted anti-
genic characterization of 10 Ontario H3N2 viruses iso-
lated from swine in 2011 and 2012. On the basis of
these results it can be concluded that at least three dif-
ferent groups of H3N2 viruses were circulating in On-
tario swine during that time.
Group 1 represents viruses similar to the original
trH3N2 viruses with gene segments of avian (PB2, PA),
human (PB1, HA, NA) and classical swine (NP, M, NS)
influenza virus origin. These 4 trH3N2 genotype viruses,
with a mix of classical avian, human and swine virus lin-
eages, emerged in 1998 and rapidly spread throughout
the US swine population [12,13]. In 2005, the spread of
these viruses to Canada were reported in Canadian
swine, turkey, and mink populations [3,4]. Group 2 rep-
resents viruses with HA, NA, PB1, and NS genes closely
related to trH3N2 viruses. The remaining internal genes
are genetically related to A(H1N1)pdm09 virus. These 4
Ontario H3N2 viruses exhibited the same gene assem-
blage as those found in trH3N2 influenza viruses iso-
lated from breeder turkey flocks in Southern Ontario
during 2011 (FAV-009 and FAV-010). Group 3 repre-
sents viruses with HA and NA genes closely related to
trH3N2 viruses, with all internal genes genetically re-
lated to A(H1N1)pdm09. Although structurally the same
gene assemblage has been observed as in the recent
Quebec isolates [14], more detailed analysis showed that
some gene segments in this group of 2 viruses were
most similar to the Ontario H3N2 historical isolatesfrom 2005, suggesting that these viruses likely were of
Ontario origin, and not introduced from Quebec, despite
frequent swine movement between the two Canadian
provinces. In 2009, a previously unrecognized H1N1
swine-origin subtype comprising a gene combination of
North American and Eurasian IAV-S was isolated from
humans in the US and Mexico [15]. This virus spread
globally as the first pandemic of the 21th century.
Shortly after the virus was first isolated from humans in
the USA and Mexico, human-to-animal transmission
was reported in Canada by Howden et al. [16] and
Berhane et al. [17]. Virus isolates from Canadian pigs
were phylogenetically similar to A(H1N1)pdm09 virus
[16,18], which is often detected in the Canadian swine
population [19]. The characterization of the Ontario
H3N2 viruses clearly indicates reassortment of gene seg-
ments between the North American swine trH3N2 from
Cluster IV and the A(H1N1)pdm09. Structurally similar
viruses have been observed on multiple occasions since
A(H1N1)pdm09 emerged in 2009 [4,20]. More recently,
Kitikon et al. [21] reported at least ten unique groups of
H3N2 reassortants based on H3N2/H1N1pdm(09) gene
combination. Findings in this study have implications for
animal and public health, because H3N2 viruses with
the matrix gene from H1N1pdm09 were implicated in
influenza outbreaks in people attending agricultural fairs
in US in 2012 [22-24], showed efficient droplet trans-
mission in experimental studies on ferrets [25], and in-
creased person-to-person transmissibility in modelling
studies based on outbreak data in people [26].
The percentage of aa identity of HA1 between the pro-
totype Cluster IV trH3N2 virus [A/swine/Ontario/33853/
2005/(H3N2)] and 10 Ontario H3N2 viruses ranged from
94.5% to 95.7%. We detected 8 aa changes at 4 antigenic
sites (A, B, C and E) for Group 1 viruses, 8 aa changes at 3
antigenic sites (A, B and C) for Group 2, and 4 aa changes
at 3 antigenic sites (B, D and E) for Group 3. According to
Wilson and Cox [27], a drift variant with ≥4 aa changes
at ≥2 of 5 antigenic sites could be of epidemiologic import-
ance. Additionally, Wood et al. [28] and Kodihalli et al. [29]
have shown that 1 to 3 aa changes in the HA1 of H1N1
and H3N2 viruses can reduce cross reactivity and efficacy
of inactivated vaccine. This leaves open the possibility that
several variants of H3N2 could co-circulate in the same
population. However, more detailed serological studies and
field studies should be done to better appreciate the poten-
tial for such co-circulation or the frequency with which this
occurs.
Although, the Ontario H3N2 viruses from this study
shared 5 potential N-linked glycosylation sites at posi-
tions 22, 38, 63, 126, and 285 with the closely related
cluster IV A/swine/Ontario/33853/2005/(H3N2) virus,
Group 2 (4 viruses) lacked a potential glycosylation site
at position 126, Group 1 (4 viruses) had an additional
Grgić et al. Virology Journal 2014, 11:194 Page 12 of 14
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Group 1 lacked a glycosylation site at position 165. The
existence of N-glycosylation is essential for viral mem-
brane glycoproteins. The N-glycans encode required infor-
mation for folding, maturation, transport or degradation
of proteins [30]. Glycosylation seems to be one mechan-
ism by which a virus masks its epitopes and escapes
neutralization by the host antibodies [31,32]. However, the
study of Vigerust et al. [33] linked increased glycosylation
of influenza viruses with decreased virulence.
The M2 is the target of the anti-influenza drugs amanta-
dine and rimantadine. Resistance-associated mutation to
adamantanes S31N has been detected in 6 Ontario H3N2
viruses indicating resistance to amantadine and rimanta-
dine. According to our findings at least 6 Ontario swH3N2
viruses out of 10 evaluated can be expected to offer resist-
ance to amantadine and rimantadine.
In conclusion, this study showed that at least 3 differ-
ent variants of H3N2 viruses circulated in Ontario swine
in 2011 and 2012. Group 1 viruses are most closely re-
lated to trH3N2 viruses from 2005 [3]. Group 2 viruses
are closely related to H3N2 viruses that were previously
reported in Ontario turkeys [6]. It is important to note
that there were no clear epidemiological linkages among
swine and turkey farms with detected viruses, although
no detailed disease investigations were performed as a
part of this study. Group 3 viruses are most closely re-
lated to swH3N2/A(H1N1)pdm09 reassortant viruses
from swine in the province of Quebec, but are likely of
Ontario origin. According to amino acid sequence ana-
lysis of the M2 protein, Ontario H3N2 viruses can be ex-
pected to offer resistance to adamantane derivatives, but
not to neuraminidase inhibitors.Materials and methods
Study populations
Invitation for participation in the study was distributed
through the Ontario Association of Swine Veterinarians’
email distribution list. Inclusion criterion for these herds
was the current or recent presence of clinical signs sug-
gestive of infection with influenza A virus as indicated by
a herd veterinarian. Twenty-one Ontario swine herds were
sampled between November 2011 and May 2013, with the
majority of 18 herds sampled in 2012. Groups and animals
showing clinical signs suggestive of influenza were tar-
geted for sampling. Dacron-tipped nasal swabs were col-
lected from both nostrils of individual animals, deposited
in PBS, and transported to a virology laboratory (Depart-
ment of Pathobiology, University of Guelph). Nasal swabs
were either tested within 24 h or frozen at −80°C before
being inoculated in MDCK cells. The originally planned
sample size was 100 per herd, sufficient to detect a preva-
lence of infection between 2% and 3%. However, actualsample size varied depending on the prevalence of clinical
signs and resources available for sampling.
In twelve of those 21 herds an additional 30 nasal
swabs were collected from individual animals with clin-
ical signs indicative of influenza. These samples were
transported in 2 ml of VTM and submitted to the Ani-
mal Health Laboratory (AHL, University of Guelph, ON,
Canada). The samples were then pooled 3:1 and tested
with a rtRT-PCR directed to the matrix protein of influ-
enza A viruses.
Eleven viruses from 10 herds that tested positive for
H3N2 influenza virus were included in the full genome
sequencing study. The viruses were selected purposively
so that only one farm per production system was in-
cluded. For 9 herds, one randomly selected virus was in-
cluded; and for one herd, 2 randomly selected viruses
were included.
Samples submitted to the virology laboratory of the
department of pathobiology
Swab samples were added to MDCK cells as described
elsewhere [34]. Virus isolates were identified by a he-
magglutination (HA) assay, as described elsewhere [34].
Viral RNA was extracted using the RNeasy Mini Kit ac-
cording to the manufacturer’s instructions (Qiagen Inc.,
Valencia, CA, USA). Briefly, the cDNA was synthesized
with Random Primer (Invitrogen, Canada Inc., Burlington,
ON, Canada) and by SuperScript™ II Reverse Transcript-
ase, Invitrogen, Canada Inc Burlington, ON, Canada) ac-
cording to the manufacturer’s instruction. The subtype
was determined by reverse transcription (RT-PCR) and
further characterized by full genome sequencing using
454 sequencing technology. The RT-PCR subtyping was
performed on the harvested virus infected cell culture
supernatant, as identified by CPE and HA. Primer pairs
utilized in study for subtype determination were: HA gene
(subtype H1Forw 5′-GTTCTGCTATATACATTTGC-3′,
H1Rev 5′-GACCCATTAGAGCACATC-3′ or H3Forw
5′-GGA-AGT-GAC-AAC-AGC-AT-3′, H3Rev (5′-AGC-
TGA-ACA-CCT-TTG-ATC-T-3′) 5′- and NA gene (sub-
type N1Forw 5′- TAACATCAGCAACATCAACT-3′,
N1Rev GTCGCCCTCTGATTAGTT-3′ or N2 Forw 5′-
GGCTCTGTTTCTCTCATC-3′, N Rev 5′- CAAGTCC
TGAGCATACATA-3′). The PCR was performed with
35 cycles of 94°C for 15 s, 54°C for 30s, and 72°C for 60 s.
The results of the RT-PCR assay designated the influenza
virus type A virus to be either subtype H1N1 or H3N2.
Samples submitted to the AHL
Viral RNA was extracted on an automated platform using
the MagMAX™ Express-96 instrument and MagMAX™ 96
Viral RNA Isolation kit (cat#AM1836), according to the
manufacturer’s instructions. To identify swine influenza
A viruses a rtRT-PCR was used with matrix primers
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hanced for the detection of A(H1N1)pdm09, using SIV
Forward Primer - 5′d AGA TGA GTC YTC TAA CCG
AGG TCG 3′; SIV Reverse Primer - 5′d TGC AAA RAC
AYY TTC MAG TCT CTG 3′. An AIV M+ 64 Probe -5′
FAM-TCA GGC CCC CTC AAA GCC GA-BHQ-1 3′de-
signed by Spackman et al. [35] was used. The probe was
purchased from Biosearch Technologies as Reference #
SS113269-29. These were used in combination with the
Ambion AgPath-ID one-step RT-PCR Kit Cat #AM1005,
according to the manufacturer’s instructions.
If the matrix rtRT-PCR was positive, then the speci-
men was processed for virus isolation using MDCK cells
and rtRT-PCR subtyping was performed on the har-
vested virus infected cell culture supernatant, as identi-
fied by CPE and HA using chicken, turkey or guinea pig
red blood cells. Where large concentrations of virus
were present in clinical samples, as evidenced by low CT
values in the matrix rtRT-PCR, subtyping was attempted
directly from clinical samples. However in the majority
of cases clinical samples did not have high enough levels
of viral RNA for successful subtyping and cell culture
supernatant was used.
The first step for subtyping was initial production of
complementary DNA (cDNA) from RNA extracted from
MDCK or allantoic fluid culture isolates using random
hexamer priming and MuLV reverse transcriptase. Dur-
ing the second step the cDNA was amplified using single
primer pairs to type the isolate as H1N1 or H3N2. Pri-
mer pairs were complementary to the HA gene (subtype
H1 -612 F5′-GGT GTG ACG GCA GCA TGC CCT-3′;
H1 612 R 5′-AGC AAT GGC TCC AAA CAG ACC-3′
or H3 722 F 5′-CARATTGARGTGACHAATGC-3′; H3
722 R 5′-GGTGCATCTGAYCTCATTA-3′) and the NA
gene (subtype N1 533 F 5′-CTT CCT ATC CAA ACA
CCA TT-3′; N1 533 R5′-TTG CTT GGT CAG CAA
GTG-3′ or N2 385 F 5′-ACGACAGATCCAGCAG
TAGC-3′; N2 385R 5′-GAGCCTGTTCCATATGTACC-
3′). The results of the rtRT-PCR assay designated the in-
fluenza virus type A virus to be either subtype H1N1,
H3N2 or an unknown virus.
Genomic sequencing and sequence assembly
The complete nucleotide sequences of 10 viruses were
determined using the 454 GS Junior Titanium platform
(Roche Applied Science, Indianapolis, IN, USA). In brief,
RNA of all viruses was fragmented by ZnCl2 into frag-
ments between 500 bp and 1500 bp. Sheared RNA was
used for first and second strand cDNA synthesis and
fragment end repair. The 454 rapid library multiplex
identifier (RL MID) was ligated to the fragments accord-
ing to the GS Junior Titanium cDNA rapid library prep-
aration method (Roche) by incubating with ligase at 25C
° for 10 min. Quality assessment of the RNA samplesand of the DNA library was performed using the FlashGel
system. The nucleotide sequence reads obtained were as-
sembled using the Newbler (version 2.5p1) de novo se-
quence assembly software (Roche). Comparison of the de
novo contigs by BLAST with known influenza A virus se-
quences allowed identification of all genes. Sanger sequen-
cing applying targeted oligo primers was utilized to walk
across gaps. BLASTN and BLASTX analyses were per-
formed to compare the established sequences to known
influenza A viruses in the NCBI database.
Sequence analysis
To determine gene relatedness of each gene segment of
the Ontario swine H3N2 isolates, we used BLAST from
the GenBank database. Geneious Pro 5.5.6. has been used
to determine nucleotide and amino acid (aa) sequence
identities. The CLUSTAL W alignment method was ap-
plied, and an unrooted phylogenetic tree of the HA gene
was constructed by using the distance-based neighbor-
joining method. To predict N-linked glycosylation sites
(Asn-X-Ser/Thr, where X is any aa except Pro) we applied
the NetNGlyc 1.0 server.
The University of Guelph Animal Care Committee and
the Ethics Committee approved this study.
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